Qritive’s Post

It has been reported that #AI can enhance ‘diagnostic accuracy, trust, and confidence among dermatologists’. However, when physicians make decisions with AI, errors can still occur: We agree that more research is needed to better understand how to identify and avoid human-AI collaboration errors, to meet the full potential of AI-supported decision making. https://bit.ly/3XBPZ0a   AMLo Biosciences are working on both machine learning and #AI applications to further enhance the risk stratification accuracy of our biomarker prognostic #AMBLor that accurately identifies early-stage melanomas at low risk of progression. We believe that practitioner-led AI will bring improvements to healthcare. #dermatology #dermatopathology #histopathology #oncology #skincancer #cancerresearch #biomarkers #melanoma

Here at AMLo Biosciences we are focused on developing prognostic tests for early stage #melanoma to help clinicians better identify patients' true risk of disease progression. So, we were interested to read a Norwegian study looking at the incidence and factors that accompany second primary invasive melanomas. Using retrospective data, the study revealed that older age and male sex were associated with an increased risk of a second primary tumour. The investigators advise that increased surveillance should be considered for men (especially over 50 years) for a minimum of 3 years post-initial diagnosis.  https://bit.ly/43XdbaG www.amlo-biosciences.com #dermatology #dermatopathology #histopathology #oncology #skincancer #cancerresearch #biomarkers  

I'm excited to announce that I will be participating as a speaker in an upcoming online webinar titled "Different Modes of Action in Atopic Dermatitis" on July 31, 2024, from 20:00 to 21:00. I will be presenting "Unraveling the Pathomechanisms of Atopic Dermatitis: Insights and Innovations," where I'll delve into the latest research and advancements in understanding and treating this complex condition. Joining me is Professor Alon Hershko, who will discuss "The Atopic March – Different Diseases with a Common Mechanism." Together, we aim to provide a comprehensive overview of atopic dermatitis and related conditions. The event will conclude with a panel discussion, allowing for an interactive and engaging session with our audience. For more details and registration, please refer to the following link: https://lnkd.in/dqUJAY6t. Looking forward to a productive session and hoping to see many of you there! #Dermatology #AtopicDermatitis #Webinar #MedicalEducation #Research

Call for Speaker and Poster Presenters!! Join us to learn about the #pathology #Digitalpathology #Cancer at the CME/CPD accredited #14EPUCG2024 Conference from December 17-19, 2024, in Dubai, UAE & Virtual. Submit your abstract/case study/research papers here: https://lnkd.in/dCyUPQh7 #PathologyTechnology #Dermatopathology #Diagnosticpathology #SurgicalPathology #PathologySpecialization #Histopathology #CancerCytopathology #GenomicFrontiers #PathologyResearch #PathologyStudy #PathologyScience #PathologyInvestigation

The second visual in AMLo Biosciences #MelanomaMay series looks at how melanoma-associated #anxiety can affect family life. Being diagnosed with #melanoma, the most aggressive form of #skincancer, is an extremely emotional experience. Despite the fact that only around 15% of early-stage melanomas will progress into later stage disease, the anxiety around fear of recurrence can be debilitating for some patients. Patients worry about parenting their children, caring for relatives and planning for the future. With our prognostic #biomarker technology, clinicians can identity early-stage melanomas that are at low risk of progression. This information can offer some reassurance to these patients. Find out more: www.amlo-biosciences.com #dermatology #dermatopathology #histopathology #oncology #skincancer #cancerresearch #biomarkers #knowyourskin

We're excited to announce the official launch of the Myositis Clinical Trials Consortium (MCTC) LinkedIn page! MCTC is a global alliance dedicated to advancing research and treatments for idiopathic inflammatory myopathies (IIM). Our mission is to facilitate, coordinate, and conduct clinical trials that drive progress in the field of myositis. Follow our page for updates on groundbreaking research, clinical trials, and advancements in myositis treatment. Together, we're working towards a future with better outcomes for patients living with myositis. #Myositis #ClinicalTrials #ClinicalResearch #AutoimmuneDisease #Rheumatology #Neurology #Pulmonology #Dermatology #Rehabilitation

This is such an important subject and a big thanks to British In Vitro Diagnostics Association (BIVDA) for raising it at a Parliamentary Reception this week. Getting innovations into the NHS is challenging, especially for SMEs who have limited resources and significant pressures from their investors to get sales. One of the unfortunate consequences of this is that SMEs are forced to focus their efforts on larger international markets with quicker pathways to adoption, and UK patients cannot access homegrown innovations. Surely there must be a way to reduce the barriers to adoption to ensure British innovations are available in their home market first? #skincancer #melanoma #diagnostic # innovation #AMBLor

🆕A new study from the factory of the center for #digialhealth at Stanford University School of Medicine led by Isabelle Krakowski and Eleni Linos demonstrate how #AI can be used in collaboration with #physicians to improve #diagnosis of #skincancer. 📕Link to paper: https://lnkd.in/euEGDxZp 👉Learn more about #HealthAI at the DHAI Summit in Boston: https://lnkd.in/emuGUEmW #dermatology #cancer #artificalintellegince #medicine #healthcare #deeplearning #algorithms #healthcareai

Call for Speaker/Poster Presenters/Delegate!! Join us to learn about the #pathology #Digitalpathology #Cancer at the CME/CPD accredited #14EPUCG2024 Conference from December 17-19, 2024 in Dubai, UAE & Virtual. Submit your abstract/research papers here: https://lnkd.in/dCyUPQh7 🔗 60% Discounted registration link here: https://lnkd.in/dkg6y5pC #PathologyTechnology #Dermatopathology #Diagnosticpathology #SurgicalPathology #PathologySpecialization #Histopathology #CancerCytopathology #GenomicFrontiers #PathologyResearch #PathologyStudy #PathologyScience #PathologyInvestigation

𝐅𝐃𝐀 𝐜𝐥𝐞𝐚𝐫𝐬 IceCure Medical'𝐬 𝐧𝐞𝐱𝐭-𝐠𝐞𝐧 𝐬𝐢𝐧𝐠𝐥𝐞-𝐩𝐫𝐨𝐛𝐞 𝐜𝐫𝐲𝐨𝐚𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐬𝐲𝐬𝐭𝐞𝐦 ❄ IceCure Medical has received #FDA approval for its new #XSense #cryoablation system with #cryoprobes. The technology has applications across #minimallyinvasive procedures in #generalsurgery, #dermatology, #neurology, #oncology, #thoracicsurgery #ent #gynecology and #urology. The system targets various tissues and tumors, including #fibroadenomas, #kidney tissue, liver metastases, skin #lesions, and uses #liquidnitrogen for effective tumor destruction, aiming to improve recovery and reduce pain and surgical risks. It is designed to be easily transportable for convenient office-based procedures. Congrats Eyal Shamir and IceCure Medical team! ❄ #medtech #medicaldevice #fdaapproval #cryoablation #oncology #urology #executivesearch #recruitment #fda #innovation #healthtech #gyn #ablation #cancertreatment